Insider: Stonehouse Jon P President & CEO - BIOCRYST PHARMACEUTICALS INC
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 1,127,770 | 0 | 1,127,770 |
| Value | $8,627,440.50 | $0.00 | $8,627,440.50 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 05/13/2024 | AAP | 30,000 | Direct | COM | $5.55 | $166,500.00 | 1,127,770 |
| 02/01/2023 | DDS | 100,000 | Direct | COM | $10.38 | $1,038,000.00 | 1,008,739 |
| 12/15/2022 | DDS | 14,100 | Direct | COM | $10.90 | $153,690.00 | 887,730 |
| 12/02/2022 | DDS | 82,656 | Direct | COM | $12.80 | $1,057,996.80 | 901,830 |
| 12/01/2022 | DDS | 214,917 | Direct | COM | $13.00 | $2,793,921.00 | 901,830 |
| 01/11/2022 | DDS | 184,000 | Direct | COM | $15.04 | $2,767,360.00 | 901,602 |
| 12/15/2020 | DDS | 134,278 | Direct | COM | $8.32 | $1,117,192.96 | 784,086 |
| 11/18/2019 | AAP | 50,000 | Direct | COM | $1.45 | $72,500.00 | 778,086 |
| 12/03/2018 | DDS | 80,000 | Direct | COM | $9.12 | $729,600.00 | 727,674 |
| 06/19/2015 | DDS | 20,000 | Direct | COM | $15.02 | $300,400.00 | 650,869 |
| 03/02/2012 | DDS | 2,721 | Direct | COM | $4.78 | $13,006.38 | 239,384 |
| 08/08/2011 | AAP | 10,000 | Direct | COM | $2.52 | $25,190.00 | 217,492 |
| 03/18/2011 | AAP | 10,000 | Direct | COM | $3.40 | $33,988.00 | 194,180 |
| 01/30/2009 | AAP | 3,000 | Direct | COM | $1.62 | $4,845.00 | 103,603 |
| 12/01/2008 | AAP | 55,000 | Direct | COM | $1.48 | $81,449.50 | 155,603 |
| 11/03/2008 | AAP | 2,100 | Direct | COM | $1.74 | $3,654.00 | 77,703 |
| 11/03/2008 | AAP | 22,900 | Direct | COM | $1.75 | $40,075.00 | 100,603 |
| 08/12/2008 | AAP | 2,300 | Direct | COM | $3.10 | $7,124.25 | 75,603 |
| 08/11/2008 | AAP | 7,700 | Direct | COM | $2.95 | $22,735.79 | 73,303 |
| 08/04/2008 | AAP | 240 | Direct | COM | $2.82 | $677.28 | 65,603 |
| 01/31/2008 | AAP | 3,000 | Direct | COM | $3.50 | $10,506.00 | 65,363 |
| 08/14/2007 | AAP | 2,650 | Direct | COM | $9.86 | $26,129.00 | 62,363 |
| 08/13/2007 | AAP | 100 | Direct | COM | $9.80 | $980.00 | 52,563 |
| 08/13/2007 | AAP | 1,400 | Direct | COM | $9.81 | $13,734.00 | 53,963 |
| 08/13/2007 | AAP | 3,700 | Direct | COM | $9.95 | $36,815.00 | 59,713 |
| 1 2 Next Last You are at page 1 of 2 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research